The Mumbai-headquartered pharma company report a 11% increase in net profit for three months ended December 2024, rising to ₹233 crore compared to ₹210 crore in the same quarter last year.
The Mumbai-headquartered pharma company report a 11% increase in net profit for three months ended December 2024, rising to ₹233 crore compared to ₹210 crore in the same quarter last year.